-
Supply of Firdapse to Treat LEMS Not Affected by Pandemic, Catalyst Says
Catalyst Pharmaceuticals says it does not expect any disruptions in the availability of Firdapse for LEMS patients across the U.S. or Canada. Read more here.
Are you worried about how the COVID-19 pandemic will impact your access to treatments?
Sorry, there were no replies found.
Log in to reply.